ArticlePlant cell reports2025
Targeted metabolic engineering of key biosynthetic genes improves triptolide production in Tripterygium wilfordii hairy roots.
Article in Plant cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
key messageThe overexpression of key biosynthetic genes involved in triptolide production through a metabolic engineering strategy significantly enhanced triptolide accumulation in Tripterygium wilfordii hairy roots. Triptolide, the representative bioactive compound in Tripterygium wilfordii, is renowned for its potent insecticidal and pharmacological properties. In order to increase the production of triptolide, this study overexpressed several key enzyme genes related to its biosynthesis in T. wilfordii hairy roots. Specifically, the content of triptolide in hairy roots overexpressing TwTPS9 and TwTPS27 individually was found to be 1.60-fold and 1.42-fold that of the control, respectively. Co-expression of both TwTPS9 and TwTPS27 resulted in significant increase in triptolide levels, reaching approximately 2.72 times that of the control. Furthermore, overexpressing TwGGPPS and TwDXS on the basis of the double gene overexpression led to the highest triptolide production, with a yield of 12.83 mg/L, increasing to 3.18-fold compared to the control. This study offers valuable examples into the efficient biosynthesis of triptolide and is expected to lay a foundation for future industrial-scale production by mitigating its resource constraints through metabolic engineering.
Indexed as
Identifiers
40404876What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.